University of California San Francisco
Give to UCSF
Barbara Drew is leading research to solve the dangerous problem of alarm fatigue, in which clinicians turn down, turn off or tune out the alarms because they're exhausted by their frequency and false readings.
New research by scientists at UC San Francisco shows that one of the brain’s fundamental self-protection mechanisms depends on coordinated, finely calibrated teamwork among neurons and non-neural cells.
The National Institutes of Health is awarding $18.8 million, administered through UCSF, to support worldwide research on concussion and traumatic brain injury.
Lennart Mucke, MD, who directs neurological research at the Gladstone Institutes, next week will receive the ARCS Foundation’s 2013 Pacesetter Award.
Three UCSF faculty members are among the 70 newly elected members of the Institute of Medicine, considered one of the highest honors in the health sciences.
The UCSF-affiliated Ernest Gallo Clinic and Research Center has issued a second round of grants to accelerate the discovery and development of new medications to treat alcohol and substance abuse in the context of post-traumatic stress and combat injury.
Newly appointed University of California President Janet Napolitano shared a letter to the UC community.
In recent years, studies have reported inconsistent findings regarding whether calcium supplements used to prevent fractures increase the risk of heart attack.
A UCSF-led team of scientists has discovered that a gene mutation found in some bladder cancers is indicative of low-risk tumors that are unlikely to recur or progress after surgery.
The Science of Staying Younger Longer is a by-invitation symposium and panel discussion highlighting advances in scientific understanding of the biological underpinnings of aging and ideas for how to slow down age-associated disease and decline.
Through support from the Catalyst Awards, UCSF researcher Aditi Bhargava is working to develop a method for delivering small-molecules to a specific target group of cells for treatment of pain.
A UCSF opthamologist and bioengineer are collaborating to develop a tiny, flexible, implantable film that's able to deliver conventional medicines and also complex antibody-based drugs to treat eye diseases.
A team of UCSF researchers developing cell-based therapies for acute respiratory distress syndrome benefited from advisors who helped identify gaps in their development plan.
Ruben Rathnasingham, PhD, associate director of Early Translational Research at UCSF's Clinical and Translational Science Institute, is leading the team responsible for LaunchPad. In this Q&A, he discusses the project and how it can benefit researchers.